Applicant, as named in the Orange Book

Waylis Therap

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis

None.

Recent events

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (13)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Aciphex rabeprazole sodium	rabeprazole sodium	020973	open now	no listed protection
Avodart dutasteride	dutasteride	021319	open now	no listed protection
Coreg · 4 strengths carvedilol	carvedilol	020297	open now	no listed protection
Coreg Cr · 4 strengths carvedilol phosphate	carvedilol phosphate	022012	open now	no listed protection
Droxia · 3 strengths hydroxyurea	hydroxyurea	016295	open now	no listed protection
Hydrea hydroxyurea	hydroxyurea	016295	open now	no listed protection
Jalyn dutasteride; tamsulosin hydrochloride	dutasteride; tamsulosin hydrochloride	022460	open now	no listed protection
Leukeran chlorambucil	chlorambucil	010669	open now	no listed protection
Lovaza omega-3-acid ethyl esters	omega-3-acid ethyl esters	021654	open now	no listed protection
Lunesta · 3 strengths eszopiclone	eszopiclone	021476	open now	no listed protection
Myleran busulfan	busulfan	009386	open now	no listed protection
Thioguanine thioguanine	thioguanine	012429	open now	no listed protection
Valium · 3 strengths diazepam	diazepam	013263	open now	no listed protection